{"title":"[Treatment Strategies for Chronic Inflammatory Demyelinating Polyneuropathy].","authors":"Norito Kokubun","doi":"10.11477/mf.188160960770010043","DOIUrl":null,"url":null,"abstract":"<p><p>Three main treatments are available for management of chronic inflammatory demyelinating polyneuropathy (CIDP). Both induction and maintenance therapies should be considered for treatment of CIDP. Plasma exchange and intravenous immunoglobulin therapy are effective as induction treatments for CIDP, and corticosteroid administration, such as daily oral or pulse therapies, may be effective for both induction and maintenance. Recently, repeat intravenous or subcutaneous immunoglobulin infusion therapy has been introduced as maintenance treatment. Treatment strategies, including combinations of the aforementioned approaches, are required as induction and maintenance therapies for patients with CIDP.</p>","PeriodicalId":52507,"journal":{"name":"Brain and Nerve","volume":"77 1","pages":"43-48"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain and Nerve","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11477/mf.188160960770010043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Three main treatments are available for management of chronic inflammatory demyelinating polyneuropathy (CIDP). Both induction and maintenance therapies should be considered for treatment of CIDP. Plasma exchange and intravenous immunoglobulin therapy are effective as induction treatments for CIDP, and corticosteroid administration, such as daily oral or pulse therapies, may be effective for both induction and maintenance. Recently, repeat intravenous or subcutaneous immunoglobulin infusion therapy has been introduced as maintenance treatment. Treatment strategies, including combinations of the aforementioned approaches, are required as induction and maintenance therapies for patients with CIDP.